Orthofix Medical Inc
NASDAQ:OFIX
Orthofix Medical Inc
Stock-Based Compensation
Orthofix Medical Inc
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Orthofix Medical Inc
NASDAQ:OFIX
|
Stock-Based Compensation
$28.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
23%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Stock-Based Compensation
$259m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Stock-Based Compensation
$297m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Stock-Based Compensation
$243m
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Stock-Based Compensation
$662m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Stock-Based Compensation
$788.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Orthofix Medical Inc
Glance View
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,087 full-time employees. The firm is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The firm has two reporting segments: Global Spine and Global Orthopedics. The Global spine segment provide three product categories such as Bone Growth Therapies, Spinal Implants, and Biologics. Its products also consist of bone growth therapies devices, motion preservation products, spine fixation products, and orthopedics products. The Global Orthopedics offers products and solutions that allow physicians to treat a variety of orthopedic conditions in adults and children unrelated to the spine. The company distribute its products globally to hospitals and health providers.
See Also
What is Orthofix Medical Inc's Stock-Based Compensation?
Stock-Based Compensation
28.6m
USD
Based on the financial report for Sep 30, 2025, Orthofix Medical Inc's Stock-Based Compensation amounts to 28.6m USD.
What is Orthofix Medical Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
23%
Over the last year, the Stock-Based Compensation growth was 1%. The average annual Stock-Based Compensation growth rates for Orthofix Medical Inc have been 18% over the past three years , 12% over the past five years , and 23% over the past ten years .
